High K+-induced contraction requires depolarization-induced Ca2+ release from internal stores in rat gut smooth muscle

Acta Pharmacol Sin. 2009 Aug;30(8):1123-31. doi: 10.1038/aps.2009.98. Epub 2009 Jul 6.

Abstract

Aim: Depolarization-induced contraction of smooth muscle is thought to be mediated by Ca2+ influx through voltage-gated L-type Ca2+channels. We describe a novel contraction mechanism that is independent of Ca2+ entry.

Methods: Pharmacological experiments were carried out on isolated rat gut longitudinal smooth muscle preparations, measuring isometric contraction strength upon high K+-induced depolarization.

Results: Treatment with verapamil, which presumably leads to a conformational change in the channel, completely abolished K+-induced contraction, while residual contraction still occurred when Ca2+ entry was blocked with Cd2+. These results were further confirmed by measuring intracellular Ca2+ transients using Fura-2. Co-application of Cd2+ and the ryanodine receptor blocker DHBP further reduced contraction, albeit incompletely. Additional blockage of either phospholipase C (U 73122) or inositol 1,4,5-trisphophate (IP3)receptors (2-APB) abolished most contractions, while sole application of these blockers and Cd2+ (without parallel ryanodine receptor manipulation) also resulted in incomplete contraction block.

Conclusion: We conclude that there are parallel mechanisms of depolarization-induced smooth muscle contraction via (a) Ca2+ entry and (b) Ca2+ entry-independent, depolarization-induced Ca2+-release through ryanodine receptors and IP3, with the latter being dependent on phospholipase C activation.

MeSH terms

  • Acetylcholine / metabolism
  • Animals
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Inositol 1,4,5-Trisphosphate Receptors / metabolism
  • Intestine, Small / metabolism*
  • Male
  • Muscle Contraction* / drug effects
  • Muscle, Smooth / metabolism*
  • Potassium / metabolism*
  • Rats
  • Rats, Wistar
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Type C Phospholipases / metabolism
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Inositol 1,4,5-Trisphosphate Receptors
  • Ryanodine Receptor Calcium Release Channel
  • Verapamil
  • Type C Phospholipases
  • Acetylcholine
  • Potassium
  • Calcium